Big brand-drug executives announced Thursday (July 9) that they’ve created a $1 billion fund to help small- to mid-sized companies develop breakthrough antibiotics because, they said, the market is broken and resistance to existing antibiotics is growing. However, they said the fund merely buys time for Congress to make changes to Medicare policy that would create a market for the new antibiotics. About 20 brand drug makers are contributing to the fund, and they’re also offering their expertise in dealing...